Company intelligence / Profile preview

Flexomics

Waltham, Massachusetts, United Statesflexomics.com ↗
Ownership
Private
Employees
~10
Development stage
Preclinical
01

Overview

Flexomics provides an integrated high-throughput single-cell biology platform that combines fluorescence microscopy with single-cell genomics. This enables simultaneous phenotypic and molecular profiling at scale, accelerating biologic drug discovery and development. The company's FLEX picowell chip allows miniaturized live cell assays across tens to hundreds of thousands of cells per run. Their optical barcoding links imaging data with sequencing results in a seamless workflow. The technology supports rapid identification and optimization of high-value biologics—including neoantigen-specific TCRs—and empowers personalized medicine efforts by capturing cellular heterogeneity more comprehensively than traditional methods.

Therapeutic areas
Other
Modalities
Biologic (enabling discovery and optimization)Screening platform (technology modality)Single-cell genomics (platform/technology)Imaging-based phenotypic analysis (platform/technology)
Industry
Drug Discovery Services
02

Partnerships

Actively seeking partnerships with biopharma companies developing next-generation therapies.(No public information on named partners as of June 2025.)

Beyond the preview

Go deeper on Flexomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flexomics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call